AMCP in the News
2024
Chapman University
October 21, 2024: AMCP Awards Tinarena Awaradia the Nexus Scholarship
Managed Healthcare Executive
October 20, 2024: MHE Week in Review – AMCP Nexus 2024
Managed Healthcare Executive
October 18, 2024: In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Managed Healthcare Executive
October 18, 2024: How Technology Benefits Specialty Pharmacy | AMCP 2024
Managed Healthcare Executive
October 18, 2024: Cancer’s Reign Over the Drug Development Pipeline Continues | AMCP Nexus 2024
AJMC
October 17, 2024: AMCP’s Adam Colborn Discusses Aspects of the IRA and Impact on Patients
Managed Healthcare Executive
October 16, 2024: Why PIE is Not the Norm and Why It Works | AMCP Nexus 2024
Managed Healthcare Executive
October 16, 2024: What Upcoming Part D Changes Could Mean for Medicare Beneficiaries | AMCP Nexus 2024
Managed Healthcare Executive
October 16, 2024: Shift Towards Medicare Advantage Plans Anticipated Amid Rising PDP Premiums and Decreased Options | AMCP 2024
Managed Healthcare Executive
October 16, 2024: Preapproval Information Exchange Act Basics | AMCP Nexus 2024
Managed Healthcare Executive
October 16, 2024: Humira Biosimilars Got Off to a Slow Start. Has That Changed? | AMCP Nexus 2024
AJMC
October 10, 2024: Legislative Updates, GLP-1s, and More at AMCP Nexus – Adam Colborn
American Journal of Managed Care
April 9, 2024: AMCP 2024 to Bring Opportunities for Managed Care Pharmacy Stakeholders to Explore, Address Policy Challenges
HealthPayerIntelligence
April 9, 2024: How are Medicare plans lowering drug costs for beneficiaries?
Managed Healthcare Executive
March 6, 2024: AMCP CEO Discusses Adherence, Out-of-Pocket Costs, and Concerns over the Inflation Reduction Act
Managed Healthcare Executive
March 1, 2024: AMCP’s Susan Cantrell Suggests Collaborative Solutions to Address High Drug Prices and Healthcare Disparities in Underserved Communities
Managed Healthcare Executive
February 29, 2024: AMCP CEO Susan Cantrell Addresses Complex Causes of High Drug Prices and Advocates for Multi-Stakeholder Solutions in US Healthcare
Leukemia & Lymphoma Society
January 30, 2024: 25 Patient and Provider Groups Urge Supreme Court to Preserve FDA Authority
Chain Drug Review
January 8, 2024: Health care outlook 2024: Susan Cantrell, CEO, AMCP
Specialty Pharmacy Continuum
January 10, 2024: AMCP Report Illustrates Benefits of Managed Care Pharmacy
2023
Pharmacy Quality Alliance
December 14, 2023: Pharmacy Quality Alliance Appoints 2024 Board of Directors and Executive Committee
Pharmaphorum
December 13, 2023: Prescription digital therapeutics show tremendous promise to improve - and save - lives
Managed Healthcare Executive
October 18, 2023: AMCP's Adam Colborn Talks Court Ruling's Impact on Employer Pharmacy Benefits and CalRX Insulin Cap | AMCP Nexus 2023
Managed Healthcare Executive
October 18, 2023: Adam Colborn of AMCP Gives a Legislative, Regulatory Update in the Pharmacy Space and Shares Concern on OOP Medicare Part D Copay Assistance | AMCP Nexus 2023
American Journal of Managed Care
October 12, 2023: AMCP’s Jennifer Mathieu Previews AMCP Nexus 2023
Pharmacy Times
October 11, 2023: Expert: What to Expect From AMCP Nexus 2023
American Journal of Managed Care
October 11, 2023: AMCP Nexus 2023 to Showcase Regulatory, Policy Updates and Evolving Managed Care Strategies
Science & Enterprise
October 10, 2023: FDA Funds Study of Real World Data for Biosimilars
MobiHealthNews
September 22, 2023: Q&A: The status of the Access to Prescription Digital Therapeutics Act
Policy & Medicine
September 13, 2023: Bipartisan Legislation Introduced to Authorize PDTs in Medicare and Medicaid
Managed Healthcare Executive
July 26, 2023: 2023 Halftime Report — Retail Healthcare, Price Transparency, Evolution of Medicaid Programs
Managed Healthcare Executive
July 25, 2023: 2023 Halftime Report — Price Negotiation, PBM Legislation, Med Shortages
American Journal of Managed Care
July 3, 2023: AMCP's Adam Colborn Explains Obstacles, Solutions for Interchangeability in the Biosimilars Market
Associations Now
June 26, 2023: Turn to Friendly Competition to Drive Affiliate Growth
Managed Healthcare Executive
May 26, 2023: Access to Prescription Digital Therapeutics Act of 2023
Health Affairs
May 16, 2023: Patient Engagement & Experience Data: Missing Ingredients For CMS’ Successful IRA Implementation
Politico
May 14, 2023: Sorry, the government’s not paying for your therapy app
Specialty Pharmacy Continuum
April 12, 2023: Preventing Claims Denials Among Priorities for 2023
Managed Healthcare Executive
March 28, 2023: PDTs, biosimilars hot topics at AMCP meeting | AMCP 2023
Managed Healthcare Executive
March 28, 2023: Yoona Kim of Arine Shares How AI Improves Medication Adherence Amongst Patients Facing Racial Disparities l AMCP 2023
Managed Healthcare Executive
March 27, 2023: Gene Therapy for Hemophilia Is Becoming a Reality. Who Will Write the Checks to Pay for It?
American Journal of Managed Care
March 25, 2023: Douglas Long Highlights Key Trends in Health Care, Pharmaceutical Marketplace
American Journal of Managed Care
March 25, 2023: Getting Ophthalmic Biosimilars to Market Continues to Prove Difficult
American Journal of Managed Care
March 25, 2023: How Real-Time Benefit Check Can Improve Prescriber Decision-Making and Treatment Uptake
American Journal of Managed Care
March 25, 2023: What Are Some Health Plan Best Practices Surrounding Oncology Therapy Coverage?
American Journal of Managed Care
March 25, 2023: Jeffrey Casberg on Breakthrough Ophthalmic Drugs That Payers, Pharmacists Should Pay Attention to
Managed Healthcare Executive
March 24, 2023: Tis Full and Very, Very Expensive: the 2023 Specialty Drug Pipeline | AMCP 2023
Managed Healthcare Executive
March 24, 2023: Sharon Jhawar Breaks Down the Relationship Between Racial Health Disparities & Medication Adherence | AMCP 2023
Managed Healthcare Executive
March 24, 2023: Jane Barlow of Real Endpoints Gives an Industry Update on Value-based Contracts & What's Working, What's Not | AMCP 2023
Managed Healthcare Executive
March 24, 2023: Melissa Andel of CommonHealth Dives Into the Inflation Reduction Act & What May Come at AMCP 2023
Managed Healthcare Executive
March 24, 2023: Some Things Old, Many Things New When It Comes to Payer PDT Review | AMCP 2023
Specialty Pharmacy Continuum
March 24, 2023: Acthar Gel Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis
Syndicated in: Pharmacy Practice News
Specialty Pharmacy Continuum
March 24, 2023: TAPS Therapy Improves Outcomes in Patients With Essential Tremor
Syndicated in: Pharmacy Practice News
Specialty Pharmacy Continuum
March 24, 2023: 44% Higher Rate of CV Events Among Americans Who Do Not Maintain Recommended LDL-C Levels
Syndicated in: Pharmacy Practice News
American Journal of Managed Care
March 24, 2023: Ruxolitinib Cream Has Lower Number Needed to Treat for AD Compared With Other Therapies
American Journal of Managed Care
March 24, 2023: Dr Yuqian Liu Discusses Surrogate End Points, Formulary Management in the Accelerated Approval Pathway
American Journal of Managed Care
March 24, 2023: AMCP's Adam Colborn Talks Major Trends in State Managed Care Policy
American Journal of Managed Care
March 24, 2023: Is Dose Rounding the Answer to Cancer Drug Waste?
Managed Healthcare Executive
March 23, 2023: Best Practices to Improve Medical Cost Offsets Through Medication Adherence Using Real-World Data | AMCP 2023
Managed Healthcare Executive
March 23, 2023: For Weight Loss, Off-Label GLP-1s Are Increasingly the Chosen Ones | AMCP 2023
Managed Healthcare Executive
March 23, 2023: 10 Takeaways from Douglas Long, MBA | AMCP 2023
Managed Healthcare Executive
March 23, 2023: Magellan Team Discusses 'Mortgage-like' Payments For Ultra-Expensive Gene Therapies | AMCP 2023
Managed Healthcare Executive
March 23, 2023: Adeno-Associated Virus Gene Therapies in the Pipeline, Barriers to Existing Drugs and Solutions | AMCP 2023
Managed Healthcare Executive
March 23, 2023: PDTs and Part B Payment to Pharmacists for COVID-19-related Services Top AMCP Legislative Agenda | AMCP 2023
Syndicated in: Drug Topics
Pharmacy Practice News
March 23, 2023: Beta-Thalassemia Requires Specialized Management for Patients, Payors and Pharmacists
Syndicated in: Specialty Pharmacy Continuum
Specialty Pharmacy Continuum
March 23, 2023: Major Depressive Disorder Affects All Adults Living in the Home
Specialty Pharmacy Continuum
March 23, 2023: Payors Need Robust Review Processes to Prepare for Wave of Digital Therapeutics
Syndicated in: Pharmacy Practice News
American Journal of Managed Care
March 23, 2023: Where Challenges Lie in Health Disparities, Opportunities Exist for Health Equity
American Journal of Managed Care
March 23, 2023: Dr Scott Soefje Dives Into Results of Mayo Clinic's Dose Rounding Project
American Journal of Managed Care
March 23, 2023: Dr Ben Urick Explains Challenges With Current Literature Linking Medication Adherence to Medical Cost Offsets
Managed Healthcare Executive
March 22, 2023: Robin Roberts to AMCP: Enjoy the Journey | AMCP 2023
Managed Healthcare Executive
March 22, 2023: Reinsurance, Stop-Loss Programs in Managing High-Cost Meds, Per Rick Lassow of Summit Re | AMCP 2023
Managed Healthcare Executive
March 22, 2023: It's Not Just the P&T Committee. Payers Are Putting Value Assessment Committees, Filters on Drug Coverage Decisions | AMCP 2023
American Journal of Managed Care
March 22, 2023: Experts Call for a More Patient-Focused Approach to Prior Authorization
Managed Healthcare Executive
March 21, 2023: 3.5K Expected at AMCP meeting in San Antonio | AMCP 2023
Managed Healthcare Executive
March 21, 2023: Incorporating Value Framework Assessments in Coverage and Reimbursement Decisions, per Kimberly Westrich | AMCP 2023
American Journal of Managed Care
March 16, 2023: AMCP 2023 to Feature Policy, Pharmaceutical Trends, Patient-Centered Outcomes
American Journal of Managed Care
March 16, 2023: AMCP 2023 Will Cover Biosimilars, Inflation Reduction Act, and Much More, Says Kimberly Westrich
Chain Drug Review
Jan. 9, 2023: Heath Care Outlook 2023: Susan Cantrell, AMCP
FDA Law Blog
Jan. 5, 2023: The PIE Act – A Win for Patients, Payors, and Sponsors
InsideHealthPolicy
Jan. 4, 2023: Congress Passes Bill Letting Drug, Device Makers Share Info With Payers (Subscription required.)
Managed Healthcare Executive
Jan. 4, 2023: PIE Act, Now Law, Will Speed Up Access, Says AMCP CEO Susan Cantrell
2022
Pharma Intelligence
Dec. 28, 2022: Preapproval Information Exchange With Payers: Guidelines Codified In Omnibus Spending Bill
Pharmaphorum
Dec. 28, 2022: Congress delivers festive PIE to patients, speeding access to therapies
MoBiHealth News
Dec. 20, 2022: Bill could pave the way for prescription digital therapeutics reimbursement
Specialty Pharmacy Continuum
Dec. 15, 2022: Patient-Centered Models Attract Payors, Pharma
Managed Healthcare Executive
Nov. 23, 2022: Talking PIE, the Act, Before Thanksgiving
PoliticoPro
Nov. 10, 2022: FDA policy riders likely to move forward in year-end package, lobbyists say (Subscription required.)
Health Affairs
Oct. 7, 2022: A Simple Way To Safely Accelerate Patient Access To New Therapies
Pharmaphorum
June 27, 2022: How the US’s pending PIE Act will improve patient access to medication
Wayne State University
April 11, 2022: WSU Represented at The Academy of Managed Care Pharmacy 2022 National Conference
USC School of Pharmacy
April 6, 2022: Student Team Places in Top Five at AMCP Pharmacy & Therapeutics Competition
Managed Healthcare Executive
April 5, 2022: AMCP 2022 Wrap-Up
WellDyne
April 1, 2022: WellDyne Expertise on Display at AMCP
Managed Healthcare Executive
April 1, 2022: AMCP 2022: Digital Therapeutics and the Medical, Pharmacy Benefit: Which Side Should They Go On?
Managed Healthcare Executive
April 1, 2022: AMCP 2022: Walgreens Used Targeted Outreach to Boost COVID-19 Vaccination in Socially Vulnerable Areas
Managed Healthcare Executive
April 1, 2022: AMCP 2022: Research Looks at Medication Use in Rare Liver Disease
Managed Healthcare Executive
April 1, 2022: AMCP 2022: Zahra Mahmoudjafari of University of Kansas Health System Discusses CAR T-Cell Therapies in Managed Care
American Journal of Managed Care
March 31, 2022: Medication Therapy Management in TennCare Medicaid Shows Promise in Pilot Study
Managed Healthcare Executive
March 31, 2022: AMCP 2022: RWE Research Keeps Coming on Strong, Say JMCP Editor-in-Chief
Managed Healthcare Executive
March 31, 2022: AMCP 2022: Katie Lockhart of Magellan Health Talks the Financial Impact of Specialty Drugs & Cost-Impact Models
Managed Healthcare Executive
March 31, 2022: AMCP 2022: Soumya Vishwanath of Magellan Rx Management Addresses Digital Therapeutics at AMCP 2022
Managed Healthcare Executive
March 31, 2022: AMCP 2022: High Out-of-Pocket Costs Are Associated with Nonadherence Among Patients Taking Oral Cancer Drugs
American Journal of Managed Care
March 30, 2022: Michael Ciarametaro Talks About Balancing Drug Price Reform With Encouraging Innovation
Managed Healthcare Executive
March 30, 2022: AMCP 2022: Prevalence of Alopecia Areata Is Increasing
Managed Healthcare Executive
March 30, 2022: AMCP 2022: Reality-Checking Digital Therapeutics As They Take Off
Managed Healthcare Executive
March 30, 2022: AMCP 2022: Michael Ciarametaro of National Pharmaceutical Council Talks Gene Therapy, Medicaid Best Price Rule
Managed Healthcare Executive
March 30, 2022: AMCP 2022: Atopic Dermatitis Treatment Is a Good News Story, Says Symposium Panelists
Managed Healthcare Executive
March 28, 2022: AMCP 2022 Meeting Starts Tomorrow in Chicago
American Journal of Managed Care
March 25, 2022: Melissa Andel Previews Her Upcoming Session on Drug Pricing Reform at AMCP 2022
American Journal of Managed Care
March 24, 2022: Data, Disparities, Drug Pricing Take Center Stage at AMCP 2022
RX Insider
March 9, 2022: Association Between Health Systems Specialty Pharmacy Use and Health Care Costs Among National Sample of Medicare Advantage Beneficiaries
Managed Healthcare Executive
March 1, 2022: AMCP Nexus 2021 Updates on iGlarLixi in Type Two Diabetes
Chain Drug Review
Feb. 15, 2022: Academy of Managed Care Pharmacy Named AAM's 2022 Champion of Access
Chain Drug Review
Jan. 10, 2022: Pharmacy Outlook: Susan Cantrell, AMCP
Nation World News
Jan. 4, 2022: AMCP 2022: Drug Launches, The Pandemic, and Further Shaping US Health Care in 2021-2022
2021
Pharmacy Practice News
Dec. 21, 2021: Specialty Drug Approvals: A Year of Firsts
American Journal of Managed Care
Dec. 20, 2021: Conference Coverage: AMCP Nexus 2021
American Journal of Managed Care
Nov. 23, 2021: AMCP Nexus Survey: Two-Thirds of Payers Use Biosimilars to Manage Oncology Drug Costs
Shenandoah University News
Nov. 8, 2021: Bernard J. Dunn School of Pharmacy News: Fall 2021
American Journal of Managed Care
Nov. 8, 2021: AMCP Nexus Abstracts Present Findings on Clinical, Financial Burdens Associated with CKD
American Journal of Managed Care
Oct. 30, 2021: The Cost of Treating AEs Due to CAR T-Cell Therapy Treatment
American Journal of Managed Care
Oct. 25, 2021: Surveys on Biosimilar Awareness and Acceptance Reported at AMXP Nexus 2021
American Journal of Managed Care
Oct. 25, 2021: Comparing Costs and HRU for Tisagenlecucel vs Axicabtagene Ciolecucel for DLBCL
American Journal of Managed Care
Oct. 22, 2021: Zanubrutinib Cost-Effective and Cost Savings vs Ibrutinib in Waldenstrom Macroglobulinemia
IPD Analytics
Oct. 22, 2021: AMCP Nexus 2021: A Wrap-Up
Managed Healthcare Executive
Oct. 22, 2021: AMCP Nexus 2021: A Wrap-Up
American Journal of Managed Care
Oct. 21, 2021: Evaluating the High SDOH Burden for Patients With Serious Mental Illness
American Journal of Managed Care
Oct. 21, 2021: AMCP Studies Highlight Workplace Cost of Skin Care
American Journal of Managed Care
Oct. 21, 2021: AMCP Nexus: The Academy of Managed Care Pharmacy Nexus
American Journal of Managed Care
Oct. 21, 2021: Melissa Andel Speculates on Medicare Negotiating Drug Prices with Pharma Companies
Managed Healthcare Executive
Oct. 21, 2021: AMCP Nexus 2021: Theresa Juday of CVS Health Shares How CBT's For Insomnia Can Save Payers Money
Managed Healthcare Executive
Oct. 21, 2021: AMCP Nexus 2021: Brenden O'Hara of BCBS of NC Talks Innovations in Diabetes Management and What's to Come in the Next Year
Managed Healthcare Executive
Oct. 21, 2021: AMCP Nexus 2021: Biosimilars Are Gathering Momentum - and Interchangeability May Not Matter for Many of Them
Managed Healthcare Executive
Oct. 21, 2021: AMCP Nexus 2021: WellDyne's Nick Page, Pharm.D., Chief Pharmacy Office and Patty Taddei-Allen, Pharm.D., MBA, BCACP, BCGP, Discuss Precision Medicine and its Implications for Pharmacy Management
Managed Healthcare Executive
Oct. 21, 2021: AMCP Nexus 2021: Melissa Andel of CommonHealth Solutions Discusses Medicare Part D Changes, What's Expected in the Future
Managed Healthcare Executive
Oct. 21, 2021: AMCP Nexus 2021: What's Promising, What's Problematic About Prescription Digital Therapeutics
American Journal of Managed Care
Oct. 20, 2021: Panel: Biosimilar Acceptance May Be Greater Among Payers Than Previously Thought
Curta Health
Oct. 20, 2021: AMCP Nexus 2021
Managed Healthcare Executive
Oct. 20, 2021: AMCP Nexus 2021: Joan Barrett of Axene Health Partners, Nicole Bulochnik of Optum Discuss Value-based Care Models and Actuaries' Involvement
Managed Healthcare Executive
Oct. 20, 2021: AMCP Nexus 2021: How Can SCAN Turned Healthcare Disparity Talk Into Action
Managed Healthcare Executive
Oct. 20, 2021: AMCP Nexus 2021: Christina Barrington of Priority Health Talks Real-World Evidence in Managed Care
Managed Healthcare Executive
Oct. 20, 2021: AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs
American Journal of Managed Care
Oct. 19, 2021: Expert Panel Offers Insight Into Multifaceted Approach to Addressing Health Care Disparities
Pear Therapeutics
Oct. 19, 2021: Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest, Provides Roadmap for Payer Coverage Considerations
Managed Healthcare Executive
Oct. 19, 2021: AMCP Nexus 2021: The Diseases Are Rare. The Orphan Drugs Are Not.
Managed Healthcare Executive
Oct. 19, 2021: AMCP's Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the New Year
Managed Healthcare Executive
Oct. 19, 2021: AMCP's Nexus 2021: Jane F. Barlow, M.D., M.P.H., MBA, MIT Center for Biomedical Innovation, Addresses Gene, Cell Therapy and Needed Adjustments of High Costs for Payment Models
Managed Healthcare Executive
Oct. 19, 2021: AMCP's Nexus 2021: The Atopic Treatment Landscape
Managed Healthcare Executive
Oct. 19, 2021: AMCP's Nexus 2021: Aimee Loucks, Pharm.D., of Kaiser Permanente Washington Talks Metrics That Can Give Providers an Incentive to Address Disparities
Managed Healthcare Executive
Oct. 19, 2021: AMCP's Nexus 2021: What the Future May Hold for Mavacamten
Managed Healthcare Executive
Oct. 19, 2021: AMCP's Nexus 2021: The Disparate Ways of Addressing Health Disparities
Analysis Group
Oct. 15, 2021: AMCP's Annual Nexus Meeting to Feature New Outcomes Research from Analysis Group
American Journal of Managed Care
Oct. 14, 2021: AMCP Nexus Sessions Will Focus on Drug Costs and Addressing Health Disparities
MRIoA
Oct. 4, 2021: Medical Review Institute of America (MRIoA) Sponsors AMCP Nexus 2021 Annual Conference
Becker's Hospital Review
Sept. 9, 2021: How Health Systems Specialty Pharmacy Can Be an engine for Improving Health Equity
AiThority
Sept. 9, 2021: AMCP Partnership Forum Develops Steps to Strengthen Evaluation of Digital Therapeutics
American Public Health Association
July 26, 2021: Joint Statement in Support of COVID-19 Vaccine Mandates for All Workers in Health and Long-Term Care
American Medical Association
July 26, 2021: AMA in Support of COVID-19 Vaccine Mandates for Health Care Workers
American Journal of Managed Care
June 20, 2021: PATHWAYS: Oncology Care Pathways Launched By Payers: What are the Trends?
American Journal of Managed Care
May 7, 2021: Lipid Biopsy May Yield Diagnostic, Economic Benefits Over Tissue Biopsy NSCLC
Center for BioSimilars
April 26, 2021: Kaiser Permanente Study Demonstrates Equivalence for Mvasi
Pharmacy Times
April 21, 2021: New Analysis Associates Integrated Specialty Pharmacy with Lower Total Cost of Care
USC School of Pharmacy
April 16, 2021: USC Wins First-Place Team Award in AMCP Foundation's National Competition
American Journal of Managed Care
April 15, 2021: Low-Income, Non-White Patients Delay Care Using HDPDs, Study Says
American Journal of Managed Care
April 15, 2021: COVID-19's Impact on Marketplace Trends Will Continue, but Lessen
American Journal of Managed Care
April 15, 2021: PAH Treatment Patterns and Costs Related to Hospitalization
Policy & Medicine
April 14, 2021: AMCP Raises Concerns Over New ACCME Standards
American Journal of Managed Care
April 13, 2021: With PDUFA Up for Renewal, AMCP Aims for PIE Again
Global Newswire
April 13, 2021: Helsinn Announces Poster Presentation At Academy of Managed Care Pharmacy (AMCP) 2021 Virtual Meeting Evaluating Healthcare Resource Utilization in CINV
AP News
April 12, 2021: Echosens Presents at AMCP 2021 Virtual Event: "Modeling the Return on Investment of VCTE for Fatty Liver Disease (FLD) in a General Population Incorporating Device Costs"
Xcenda
April 6, 2021: Xcenda and FormularyDecisions supports AMCP 2021 virtual
RTIHS Health Solutions
March 12, 2021: 6 Takeaways on the AMCP 4.1 Guidance in Action
ExactCare Pharmacy
March 4, 2021: ExactCare Medication Management Program Proven to Reduce Average Total Cost of Care by 5 Percent for Patients with Complex Medical Needs
USC School of Pharmacy
Feb. 25, 2021: Student Spotlight: Kristine Pisikian
Wayne State University
Feb. 5, 2021: AMCP to Hold Panel Discussion on Managed Care Pharmacy Feb. 11
2020
R. Ken Coit College of Pharmacy
Dec. 21, 2020: HOPE Center Study Featured by JMCP to Commemorate 25th Anniversary
First Report — Managed Care
Dec. 14, 2020: A Look at the COVID-19 Vaccinations
Morning Consult
Oct. 6, 2020: Access to Affordable Medications on the Docket in U.S. Supreme Court Case
The Hill
Aug. 24, 2020: The USPS is a Vital Part of our Health Care System
Managed Healthcare Executive
July 17, 2020: Key Events Drive Significant Portion of Association Between Depression, Healthcare Utilization and Cost
Managed Healthcare Executive
July 6, 2020: Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds
Managed Healthcare Executive
June 16, 2020: Patients with HCC Shoulder Economic Burdens, Have Insufficient Therapeutic Options, Studies Find
Managed Healthcare Executive
June 16, 2020: ICER Reports Play Significant Role in Managed Care's Decision-Making, Study Finds
Managed Healthcare Executive
June 5, 2020: ACHP, AMCP Survey: Telehealth, Trust in Doctors, Desire for COVID-19 Testing All Get High Marks
Specialty Pharmacy Continuum
June 3, 2020: Getting Patients the Medications They Need
MultiBrief
May 28, 2020: Survey: As Expected, Patients Fearful of In-Person Visits are Turning to Telehealth
Patient Engagement HIT
May 26, 2020: Patients Anticipate Future Access to Care Troubles from COVID-19
Specialty Pharmacy Continuum
May 26, 2020: Pandemic Shakes Up Rx Marketplace
FierceHealthcare
May 21, 2020: Survey: 72% of Consumers Have Changed Healthcare Use Since COVID-19 Pandemic
Managed Healthcare Executive
May 21, 2020: Adherence to Disease-Modifying Drugs Lowers Chronic Opioid Use in Patients with Inflammatory Conditions
Managed Healthcare Executive
May 12, 2020: Claim Analysis By Specialty Pharmacist Saves health Plan $2.7 Million, Study Finds
Pharmacy Times
May 15, 2020: More Information on COVID-19 Medications, Dialogue on Health Care Coverage Needed Post COVID-19
American Journal of Managed Care
May 15, 2020: AMCP, ACHP Advocate for Health Care Improvements
Pharmacy Times
May 14, 2020: Impact of COVID-19 Leaves Lasting Impression on Pharmacies
MedCity News
April 23, 2020: Digital Therapeutics Make Strides During Pandemic, but Still Face Adoption Hurdles
Specialty Pharmacy Continuum
April 23, 2020: Digital Therapeutics Ripe for a Surge During COVID-19
American Journal of Managed Care
April 23, 2020: More Biosimilar Launches in 2020 Seen at AMCP
American Journal of Managed Care
April 20, 2020: AMCP Posters Demonstrate Value of Biosimilars
American Journal of Managed Care
April 17, 2020: Ruby Singh Previews the AMCP eLearning Days Virtual Meeting
Managed Healthcare Executive
April 11, 2020: What Are the Top Pharma Challenges Right Now?
Drug Topics
April 9, 2020: Pharmacy Groups Praise HHS Guidance Allowing Pharmacists to Provide COVID-19 Testing
Pharmacy Times
April 7, 2020: AMCP Files Amicus Brief in US Supreme Court Case Challenging PBMs
FiercePharma
March 27, 2020: Drug supplies, costs hurt by unintended consequences of COVID-19 policies, suppliers tell White House
Pharmacy Times
March 3, 2020: Evidence: Vital but Seldom Used Consistently by Payers
Managed Care Magazine
Feb. 28, 2020: Generics of the Authorized Kind
Fierce Healthcare
Jan. 25, 2020: Newly Updated Formulary Tool Aims to Help Payers Get Early Information on Unapproved Drugs
Chain Drug Review
Jan. 8, 2020: Pharmacy Outlook: Susan Cantrell, AMCP
2019
Inside Health Policy
Dec. 5, 2019: FDA Should Stay Out Of Value, Pricing Discussions, Experts Say
Gastroenterology & Endoscopy News
Nov. 17, 2019: Taking the Pain Out of Prior Authorizations: AMCP Acknowledges Problems, Offers New Best Practices to Improve Process
Managed Healthcare Executive
Nov. 14, 2019: (video) AMCP 2019 Street Team: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium
Journal of the American Pharmacists Association
Nov. 11, 2019: Pharmacists for Healthier Lives Provides Pharmacists’ Perspective on Drug Pricing and Access
The Hansen Record
Nov. 7, 2019: Pharmacy Professor Writes Book on Dangers of Opioids
Specialty Pharmacy Continuum
Sept. 10, 2019: Taking the Pain out of Prior Authorizations
Specialty Pharmacy Continuum
July 15, 2019: ‘Safe Harbor’ for Drug Rebates Remains Safe for Now
Healthcare Finance News
July 12, 2019: Trump Administration Withdraws Drug Rebate Rule
Pink Sheet
July 8, 2019: Pharma’s Bedtime Horror Stories: Gene Therapy, Digital Revolution, Pricing ‘Fixes’
First Report Managed Care
July 2019: Troubles With Drug Pricing Transparency
Radar on Drug Benefits
June 27, 2019: States Plow Ahead on ‘Subscription’ Models for Hep C Therapy
PharmaBiz.com
June 18, 2019: AMCP Develops Concepts For Effective Prior Authorization and Utilization Management Practices
Washington Post
May 15, 2019: The Costliest Drug on the Planet Will Treat Infants With Rare Disease. The Market Fight Focused on Cost and Safety is Just Getting Started.
RAPS
May 8, 2019: Updated: Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names
First Report Managed Care
May 2019: Treatment Strategies for Chronic Pain in People Dependent on Opioids
First Report Managed Care
May 2019: General Session: James Kenney and a New Look for AMCP
Center for Biosimilars
April 23, 2019: Managed Care and Specialty Pharmacy Stakeholders Weigh in on Strategies to Address Biosimilar Barriers
Pharmacy Times
April 4, 2019: AMCP Foundation Awards Pharmacy & Therapeutics Competition Winners
Specialty Pharmacy Continuum
Feb. 19, 2019: Managed Care Always in Motion: Data sharing, drug pricing part of the flux
Fortune Magazine
Feb. 5, 2019: The Best Way to Lower Drug Prices: End the Medicaid Program that Blocks Discounts
Pink Sheet
Jan. 25, 2019: (Video) Biotech Showcase 2019: Innovative Payment Models For Expensive But Curative New Therapies
AIS Health
Jan. 28, 2019: New Payment Models Emerge for Costly Pharma Therapies
AIS Health
Jan. 24, 2019: (subscription) Louisiana’s ‘Netflix’ Model for HCV Is ‘Worth Watching Closely’
